KS
Kallen Schwark
Pathology-Anatomic and Clinical Residency · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · ·
History
Research
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Cancer Cell · 2025 · 44 citations
Review · Frontiers in Oncology · 2022 · First of 13 authors · 20 citations
Biotechnology and Bioengineering · 2018 · 12 citations
- CK
7 papers

4 papers · 2 as a fellow
- AF
3 papers

3 papers

3 papers
- LM
2 papers · 2 as a resident

2 papers
- MS
2 papers



